Annual Operating Expenses
$290.70 M
+$131.68 M+82.81%
December 31, 2024
Summary
- As of March 13, 2025, TARS annual total operating expenses is $290.70 million, with the most recent change of +$131.68 million (+82.81%) on December 31, 2024.
- During the last 3 years, TARS annual operating expenses has risen by +$223.59 million (+333.17%).
- TARS annual operating expenses is now at all-time high.
Performance
TARS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$85.90 M
+$15.87 M+22.65%
December 31, 2024
Summary
- As of March 13, 2025, TARS quarterly total operating expenses is $85.90 million, with the most recent change of +$15.87 million (+22.65%) on December 31, 2024.
- Over the past year, TARS quarterly operating expenses has increased by +$15.87 million (+22.65%).
- TARS quarterly operating expenses is now at all-time high.
Performance
TARS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
TARS Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +82.8% | +22.6% |
| 3 y3 years | +333.2% | +480.0% |
| 5 y5 years | +6663.5% | +7824.6% |
TARS Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +333.2% | at high | +480.0% |
| 5 y | 5-year | at high | +6663.5% | at high | +7824.6% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Tarsus Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $290.70 M(+82.8%) | $85.90 M(+22.7%) |
| Sep 2024 | - | $70.04 M(-1.5%) |
| Jun 2024 | - | $71.11 M(+11.7%) |
| Mar 2024 | - | $63.64 M(+13.0%) |
| Dec 2023 | $159.01 M(+81.6%) | $56.31 M(+32.7%) |
| Sep 2023 | - | $42.43 M(+29.3%) |
| Jun 2023 | - | $32.82 M(+19.6%) |
| Mar 2023 | - | $27.45 M(+11.3%) |
| Dec 2022 | $87.57 M | $24.66 M(+7.7%) |
| Sep 2022 | - | $22.91 M(+14.7%) |
| Jun 2022 | - | $19.98 M(-0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $20.03 M(+35.2%) |
| Dec 2021 | $67.11 M(+148.6%) | $14.81 M(-12.3%) |
| Sep 2021 | - | $16.88 M(+20.6%) |
| Jun 2021 | - | $14.00 M(-34.7%) |
| Mar 2021 | - | $21.42 M(+86.6%) |
| Dec 2020 | $27.00 M(+528.2%) | $11.48 M(+13.2%) |
| Sep 2020 | - | $10.14 M(+210.8%) |
| Jun 2020 | - | $3.26 M(+54.1%) |
| Mar 2020 | - | $2.12 M(+95.4%) |
| Dec 2019 | $4.30 M(+218.4%) | $1.08 M(+71.2%) |
| Sep 2019 | - | $633.00 K |
| Dec 2018 | $1.35 M | - |
FAQ
- What is Tarsus Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual operating expenses year-on-year change?
- What is Tarsus Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly operating expenses year-on-year change?
What is Tarsus Pharmaceuticals annual total operating expenses?
The current annual operating expenses of TARS is $290.70 M
What is the all time high annual operating expenses for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual total operating expenses is $290.70 M
What is Tarsus Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, TARS annual total operating expenses has changed by +$131.68 M (+82.81%)
What is Tarsus Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of TARS is $85.90 M
What is the all time high quarterly operating expenses for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly total operating expenses is $85.90 M
What is Tarsus Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, TARS quarterly total operating expenses has changed by +$15.87 M (+22.65%)